Organization
Apollo Therapeutics
4 clinical trials
Clinical trial
A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-4098 Alone and/or in Combination With Azacitidine in Adults With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome/AML (MDS/AML) or Myelodysplastic Syndrome With Excess Blasts (MDS-EB)Status: Not yet recruiting, Estimated PCD: 2027-03-01
Clinical trial
A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Camoteskimab in Subjects With Adult Onset Still's DiseaseStatus: Terminated, Estimated PCD: 2022-05-24
Clinical trial
A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Clinical trial
A Phase 2a, Multicenter, Randomized, Double-blind, 16-week Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2025-02-01